Myocardial Infarction 1 |
April 20, 09:30-11:00 Rm.201 |
Beyond Evidence-Based 'To Do and Not to Do' |
Chairpersons |
伺ö, Á¤¸íÈ£ |
Panel |
±èµ¿±â, ¹ÚÁ¾¼±, ¹èÀåȯ, ÀÌÀåÈÆ, Àå±âÀ° |
09:30-09:50 |
Time Target in STEMI: D2B Time or FMC to Wire Crossing? |
À±Ã¢È¯/¼¿ïÀÇ´ë |
09:50-10:10 |
Optimizing DAPT Duration after AMI: Evidence-Based, Precision, or Personalized Medicine? |
¹Ú¿ëÈÖ/°æ»óÀÇ´ë |
10:10-10:30 |
Complete Immediate Revascularization in Primary PCI Is The New Standard of Care? |
ÀÌÁÖ¸í/¼º±Õ°üÀÇ´ë |
10:30-10:50 |
Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA); Medical Therapy and Outcome |
À±ÇõÁØ/°è¸íÀÇ´ë |
10:50-11:00 |
Discussion |
[English Session] Cardiometabolic Syndrome |
April 20, 16:10-17:40 Rm.103 |
Crosstalk in Cardiometabolic Syndrome |
Chairpersons |
Hong Seog Seo, Kwang Kon Koh |
Panel |
Sang-Hyun Kim, Ki Chul Sung, Il Suk Sohn, Sang-Ho Jo |
16:10-16:30 |
IRAK-1 Phosphorylates IRS-1 on Ser24: Crosstalk Relevant to the Pathophysiology of Cardiometabolic Syndrome |
Michael J. Quon/University of Maryland, USA |
16:30-16:40 |
Discussion |
16:40-16:55 |
Gut Microbiota and Metabolic Disorders |
Seong-Eun Kim/Ewha Womans Univ., Korea |
16:55-17:10 |
Dynamic Crosstalk between Immune System and Cardiometabolic Diseases |
Jong-Chan Youn/Hallym Univ., Korea |
17:10-17:25 |
Cardiometabolic Crosstalk in Obesity-Related Hypertension |
Sungha Park/Yonsei Univ., Korea |
17:25-17:40 |
Discussion |
[English Session] Epidemiology |
April 21, 09:00-10:30 Rm.103 |
Epidemiologic Research Using National Big Data |
Chairpersons |
Sang Hong Baek, Boyoung Joung |
Panel |
Jang-Whan Bae, Ki Chul Sung, Song Vogue Ahn, Jin Yong Hwang |
09:00-09:20 |
CVD Epidemiologic Studies Using The UK Health Improvement Network (THIN) Database |
G. Neil Thomas/ The University of Birmingham, UK |
09:20-09:35 |
CVD Burden in Cancer Patients: National Health Insurance Service-National Sample Cohort (NHIS-NSC) |
Jong-Chan Youn/Hallym Univ., Korea |
09:35-09:50 |
Long-Term Risk Factor Changes and CVD: National Health Insurance Service-Health Screening Cohort (NHIS-HEALS) |
Hyeon Chang Kim/Yonsei Univ., Korea |
09:50-10:05 |
CVD Event Ascertainment with Health Insurance Claims and Hospital Records |
Min Ho Shin/ Chonnam National Univ., Korea |
10:05-10:30 |
Discussion |
Cardiac Surgery |
April 21, 10:40-12:10 Rm.103 |
Current State-of-the-Art of Coronary Artery Surgery |
Chairpersons |
À¯°æÁ¾, À±Á¤¼· |
10:40-10:55 |
SYNTAX, EXCEL, NOBLE and Current Comparative Studies about PCI vs. CABG |
À̱âÁ¾/¿¬¼¼ÀÇ´ë |
10:55-11:10 |
Total Arterial Grafting (TAR): Should We Apply TAR to All Patients? |
Á¶±¤¸®/¼¼Á¾º´¿ø |
11:10-11:25 |
On-Pump vs. Off-Pump CABG: Which Is Better Now? |
À±¿µ³²/¿¬¼¼ÀÇ´ë |
11:25-11:40 |
Can Composite Grafting Supply The Entire Heart? |
Ȳȣ¿µ/¼¿ïÀÇ´ë |
11:40-11:50 |
How to Improve Surgical Results : Prevention of Stroke after CABG |
°ÁرÔ/°¡Å縯ÀÇ´ë |
11:50-12:00 |
How to Improve Surgical Results : Prevention of Atrial Fibrillation after CABG |
À̽ÂÇö/¿¬¼¼ÀÇ´ë |
12:00-12:10 |
Discussion |
[Joint Session] Imaging & Intervention |
April 21, 10:40-12:10 Rm.201 |
Treatment of Coronary Artery Disease: 40 Years of PCI, Where Next? |
Chairpersons |
¼ÛÀç°ü, ÇÑ±Ô·Ï |
Panel |
±è¿µÇÐ, ±èÁß¼±, ±èÇü°ü, ³²Ã¢¿í, ½Å¼ºÈñ, ÀÌ»óö, Á¤Çؾï, Á¶º´·Ä |
40 Years of PCI: We Should Know Each Other!!! |
10:40-10:55 |
PCI as Contributor to CV Outcome Improvements |
¾È¿µ±Ù/Àü³²ÀÇ´ë |
10:55-11:10 |
CV Imaging as Contributor to CV Outcome Improvements |
È«±×·ç/¿¬¼¼ÀÇ´ë |
11:10-11:25 |
Discussion |
40 Years of PCI: Invasive vs. Non-Invasive Contibution in the Management of Coronary Disease in the Contemporary Era |
11:25-11:40 |
Interventionist View: PCI Guided by FFR and IVUS |
±¸º»±Ç/¼¿ïÀÇ´ë |
11:40-11:55 |
Imaging Specialist View: Viablity Assessment with CV Imaging; Echo, Nuclear Imaging, CMR, and More |
±èÇü¼·/°è¸íÀÇ´ë |
11:55-12:10 |
Discussion |
[English Session] Basic Research 1 |
April 21, 13:10-14:30 Rm.105 |
Inflammatory Signaling in Heart and Vascular Disease |
Chairpersons |
Donghoon Choi, Youngkeun Ahn |
Panel |
Young Mi Park, Jaewon Oh, Sang-Hak Lee, Seung Hwan Han |
13:10-13:25 |
SREBP1 and Inflammatory Signaling |
Yumiko Oishi/Nippon Medical School |
13:25-13:40 |
The Roles of Myeloid Cells in Atherosclerosis |
Jae Hoon Choi/Hanyang Univ., Korea |
13:40-13:55 |
A Heart-brain-kidney Network Controls Adaptation to Cardiac Stress through Tissue Macrophage Activation |
Katsuhito Fujiu/Tokyo Univ., Japan |
13:55-14:10 |
Role of HDAC in Vascular Calcification and Cardiovascular Disease |
Gwang Hyeon Eom/ Chonnam National Univ., Korea |
14:10-14:30 |
Discussion |
[English Session] Pediatric Cardiac Surgery 1 |
April 21, 13:10-14:30 Rm.107 |
Coronary Artery Anomalies |
Chairpersons |
Young Hwan Park, Myung Chul Hyun |
Panel |
Jae Gun Kwak, Chun Soo Park, Hong Ju Shin |
13:10-13:20 |
Surgical Options for Congenital Coronary Anomalies |
Han Ki Park/Yonsei Univ., Korea |
13:20-13:30 |
Difficult Coronaries in Arterial Switch Operation |
Woong-Han Kim/ Seoul National Univ., Korea |
13:30-13:40 |
Pediatric CABG |
Ji-Hyuk Yang/ Sungkyunkwan Uiniv., Korea |
13:40-13:55 |
Current Status of Pediatric VAD Support |
Iki Adachi/Texas Children¡¯s Hospital, USA |
13:55-14:10 |
The World Database for Pediatric and Congenital Heart Surgery: A Tool for Global Quality Improvement |
James D. St. Louis/ Children¡¯s Mercy Hospital, USA |
14:10-14:30 |
Discussion |
[English Session] Basic Research 2 |
April 21, 14:40-16:00 Rm.105 |
Cardiac Metabolism |
Chairpersons |
Myeong-Chan Cho, Sang Hong Baek |
Panel |
Yong Sook Kim, Hyoung Kyu Kim, Pil-Ki Min, Hyun-Young Park, Sang-Hyun Ihm |
14:40-14:55 |
Ca2+ Regulation in Heart Failure |
Steven R. Houser/Temple Univ., USA |
14:55-15:10 |
Akt1 and Akt2 Are Required to Maintain Cardiac Contraction |
Jaetaek Kim/Chung-Ang Univ., Korea |
15:10-15:25 |
TRPC Channels in Cardiac Plasticity |
Motohiro Nishida/ National Institutes of Natural Sciences, Japan |
15:25-15:40 |
Angiotensin II Affects Inflammation Mechanisms via AMPK-Related Signalling Pathways in HL-1 Atrial Myocytes |
Hyeon Soo Kim/Korea Univ., Korea |
15:40-16:00 |
Discussion |
[English Session] Pediatric Cardiac Surgery 2 |
April 21, 14:40-16:00 Rm.107 |
Atrioventricular Valves |
Chairpersons |
Si Chan Sung, Tae Gook Jun |
Panel |
Hyungtae Kim, Yu Rim Shin, Cheul Lee |
14:40-14:52 |
Surgical Options for Ebstein¡¯s Anomaly |
Tae-Jin Yun/Ulsan Univ., Korea |
14:52-15:04 |
Management of TR in Patients with Repaired TOF |
Chang-Ha Lee/ Sejong General Hospital, Korea |
15:04-15:16 |
Surgical Options for Congenital Mitral Valve Diseases |
Cheul Lee/Catholic Univ., Korea |
15:16-15:31 |
Repair of Complete Atrioventricular Canal Defects: Surgical Techniques and Outcomes |
James D. St. Louis/ Children¡¯s Mercy Hospital, USA |
15:31-15:46 |
Cardiac Recovery on VAD |
Iki Adachi/Texas Children¡¯s Hospital, USA |
15:46-16:00 |
Discussion |
KHRS 2 |
Apr.20(Fri) 11:10-12:40 Rm.202 |
Stroke Summit: Stroke Prevention and Anticoagulation |
Chairpersons |
À̸¸¿µ, ÃÖ±âÁØ, ±è´ë°æ |
Panel |
±èµ¿Çõ, ¹è¸íȯ, ¾È¹Î¼ö, À̱¤³ë, ÃÖ¿µ |
11:10-11:20 |
Risk Stratification of Stroke and Thromboembolism in Atrial Fibrillation |
±èÅÂÈÆ/¿¬¼¼ÀÇ´ë |
11:20-11:30 |
Anticoagulation Guideline for Korean |
ÀÌÁ¤¸í/°æÈñÀÇ´ë |
11:30-11:40 |
Characteristics of NOAC |
°íÁ¡¼®/¿ø±¤ÀÇ´ë |
11:40-11:50 |
Selection Anticoagulation for High Bleeding Risk Patients |
À̱âÈ«/Àü³²ÀÇ´ë |
11:50-12:00 |
LAA Occluder |
ÀÓÈ«ÀÇ/°í·ÁÀÇ´ë |
12:00-12:15 |
Asian Strategy for Stroke Prevention in Atrial Fibrillation |
Tze-Fan Chao/ Taipei Veterans General Hospital, Taiwan |
12:15-12:40 |
Discussion |
KHRS 3 |
Apr.20(Fri) 14:30-16:00 Rm.202 |
AF Summit: Atrial Fibrillation |
Chairpersons |
±è¿µÈÆ, Â÷ÅÂÁØ, ±è´ëÇõ |
Panel |
±èÁÖ¿¬, ±èÁØÇü, ±èÁø¹è, ±èÁø¼®, ¹Úȯö |
14:30-14:40 |
Integrated Management of Atrial Fibrillation |
¹ÚÁعü/ÀÌÈÀÇ´ë |
14:40-14:50 |
Rate Control of Atrial Fibrillation |
ÃÖÀDZÙ/¼¿ïÀÇ´ë |
14:50-15:00 |
Rhythm Control of Atrial Fibrillation |
½ÉÀç¹Î/°í·ÁÀÇ´ë |
15:00-15:10 |
Outcomes of AF Ablation |
¹ÚÈñ³²/¿¬¼¼ÀÇ´ë |
15:10-15:20 |
New Techniques for Atrial Fibrillation Ablation |
ÇѼº¿í/°è¸íÀÇ´ë |
15:20-15:40 |
Scar and Atrial Fibrillation |
Nassir Marrouche/University of Utah, USA |
15:40-16:00 |
Discussion |
KHRS 4 (ºÎÁ¤¸Æ-½ÉºÎÀü Joint Session) |
Apr.21(Sat) 10:40-12:10 Rm.202 |
Device Therapy in Heart Failure |
Chairpersons |
½Åµ¿±¸, ÃÖµ¿ÁÖ |
Panel |
°¼®¹Î, ³ë½Â¿µ, ¾çÇʼº, È«¼®±Ù |
10:40-10:50 |
ICD and CRT - Benefit and Guideline |
ÀÌ¿µ¼ö/´ë±¸°¡Å縯ÀÇ´ë |
10:50-11:00 |
How to Select the Case for ICD and CRT? |
¹ÚÀçÇü/Ãæ³²ÀÇ´ë |
11:00-11:10 |
When Is Best Time to Refer Patient for CRT |
±è°èÈÆ/Àü³²ÀÇ´ë |
11:10-11:20 |
Monitoring of HF Patients with Devices |
À¯º´¼ö/¿¬¼¼ÀÇ´ë |
11:20-11:30 |
How to Prevent Inappropriate Shock? |
¹Ú½ÂÁ¤/¼º±Õ°üÀÇ´ë |
11:30-11:40 |
ICD and CRT Are More Effective in Asian HF Patients? |
Á¤º¸¿µ/¿¬¼¼ÀÇ´ë |
11:40-11:50 |
The Role of VT Ablation in the Latest Guideline |
¹ÚÇü¼·/°è¸íÀÇ´ë |
11:50-12:10 |
Discussion |
KHRS 6 |
Apr.21(Sat) 14:40-16:00 Rm.202 |
CIED and Sudden Cardiac Death |
Chairpersons |
°ûÃæÈ¯, Á¤º´Ãµ, ±è³²È£ |
Panel |
°±â¿î, ±èµ¿¹Î, ³²±ÃÁØ, À¯ÈñÅÂ, ÇÑ»óÁø |
14:40-14:50 |
Should Device-Detected AF Be Treated? |
À±³²½Ä/Àü³²ÀÇ´ë |
14:50-15:00 |
Solving Complication During CIED Followup |
±èÁØ/¿ï»êÀÇ´ë |
15:00-15:10 |
Management of CIED Infection and Lead Extraction |
¹Ú»ó¿ø/¼¼Á¾º´¿ø |
15:10-15:20 |
New Technique in CIED: Subcutaenous ICD, Leadless Pacemaker, Etc |
¼ºÁ¤ÈÆ/Â÷ÀÇ´ë |
15:20-15:30 |
Role of Genetic Testing in Arrhythmia |
ÃÖÁ¾ÀÏ/°í·ÁÀÇ´ë |
15:30-15:40 |
Substrate and Risk Stratification in ARVD/C |
Á¶¿ë±Ù/°æºÏÀÇ´ë |
15:40-16:00 |
Discussion |
KSIC 1 |
April 20, 14:30-16:00 Rm. 201 |
How to PCI: Lectures for Beginning Cardiologists |
Chairpersons |
¹Ú½ÂÁ¤, ȲÈï°ï |
Panel |
¹ÚÇå½Ä, ¾È¼º±Õ, À±°æÈ£, À̼ºÀ±, ÃÖ¼Ò¿¬, Çã½ÂÈ£ |
14:30-14:45 |
History of Interventional Cardiology  |
±ÇÇöö/¼º±Õ°üÀÇ´ë |
14:45-15:00 |
Access Site Basics: Transfemoral and Transradial Accesses & Its Closure |
À̺À±â/°¿øÀÇ´ë |
15:00-15:15 |
What You See Is Not What You Get: Using Intravascular Imaging to Complement Angiography |
È«¿µÁØ/Àü³²ÀÇ´ë |
15:15-15:30 |
Into the Heart: Catheter and Wire Selection |
ÀÌÀçȯ/Ãæ³²ÀÇ´ë |
15:30-15:45 |
Don't Be Panic: How to Manage Acute Complications  |
Àü±¹Áø/ºÎ»êÀÇ´ë |
15:45-16:00 |
Discussion |
KSIC II |
April 20, 16:10-17:40 Rm. 201 |
Dr., I Have Chest Pain: Non-interventional Management |
Chairpersons |
½Â±â¹è, ¾ÈÅÂÈÆ |
Panel |
±èµÎÀÏ, µµÁØÇü, ÀÌöȯ, äÁ¦°Ç, ÃÖÁøÈ£, Æí¿í¹ü |
16:10-16:25 |
Strategy of Non-invasive Testing  |
È«¼øÁØ/°í·ÁÀÇ´ë |
16:25-16:40 |
Antiplatelet Therapy, Before and After PCI |
¹Ú¿ëÈÖ/°æ»óÀÇ´ë |
16:40-16:55 |
Optimal Management for Dyslipidemia |
±è¼öÁß/°æÈñÀÇ´ë |
16:55-17:10 |
Antianginal Treatment, The Art of Medical Therapy  |
Á¤¿µÈÆ/°æ»óÀÇ´ë |
17:10-17:25 |
NOAC after PCI in AF Patients |
¹èÀåȯ/ÃæºÏÀÇ´ë |
17:25-17:40 |
Discussion |
KSIC III |
April 21, 09:00-10:30 Rm. 201 |
Take the Next Step in PCI: Treating Complex and Higher-Risk Indicated Patients (CHIP) |
Chairpersons |
Seung Jea Tahk, Kyoo Rok Han |
Panel |
Sang Wook Kim, Ung Kim, Hee Yeol Kim, Seok Kyu Oh, Jun-Hee Lee, Seung Hwan Han |
09:00-09:15 |
Using Imaging and Physiology Guidance in Higher Risk Patients |
Jung-Min Ahn/Ulsan Univ., Korea |
09:15-09:30 |
PCI in Calcified Lesions  |
Byeong-Keuk Kim/Yonsei Univ., Korea |
09:30-09:45 |
PCI in Bifurcation |
Sunao Nakamura/ New Tokyo Hospital, Japan |
09:45-10:00 |
PCI during AMI: Complete vs. Culprit-only Revascularization |
Joo-Yong Hahn/Sungkyunkwan Univ., Korea |
10:00-10:15 |
PCI in SVG Lesions  |
Seung-Woon Rha/Korea Univ., Korea |
10:15-10:30 |
Discussion |
KSIC IV |
April 21, 13:10-14:30 Rm. 201 |
TAVR and Beyond |
Chairpersons |
Á¤¸íÈ£, ±èÈ¿¼ö |
Panel |
°í¿µ±¹, ±èÁÖÇÑ, ¹ÚÁ¾¼±, äÀÎÈ£, ÃÖ½ÂÇõ |
13:10-13:23 |
Future Indications of TAVR: Low Risk Patients, Younger Patients, Asymptomatic Patients |
À¯Ã¶¿õ/°í·ÁÀÇ´ë |
13:23-13:36 |
Medical Treatment After TAVR  |
¹Ú´ö¿ì/¿ï»êÀÇ´ë |
13:36-13:49 |
Valve-in-valve TAVR: Technical Pearls and Outcomes |
±èÈ¿¼ö/¼¿ïÀÇ´ë |
13:49-14:02 |
Durability of TAVR Valve : Bench Test & Clinical Evidence Compared with SAVR |
Àå±âÀ°/°¡Å縯ÀÇ´ë |
14:02-14:15 |
Transcatheter Mitral and Tricuspid Valve Therapies  |
±èÁØÈ«/ºÎ»êÀÇ´ë |
14:15-14:30 |
Discussion |
KSoLA 1 |
April 20, 09:30-11:00 Rm. 107 |
Vascular Inflammation and Remodeling |
Chairpersons |
±èÈ¿¼ö, ¿À±¸Åà |
Panel |
¹Ú¿µ¹Ì, ¹ÚÁ¾±æ, Á¶°æÇö, Á¶ÇöÀç, ÇÑÁø |
09:30-09:50 |
Role of Dendritic Cells in Vascular Inflammation  |
ÃÖÀçÈÆ/ÇѾç´ë |
09:50-10:10 |
Vessel Remodeling in Pulmonary Hypertension  |
±èÁ¾¹Î/¼÷¸í¿©´ë |
10:10-10:30 |
Vessel Remodeling in Diabetic Retinopathy  |
À±Ã¢È¯/¼¿ïÀÇ´ë |
10:30-10:50 |
Regulation of Atherosclerosis by Calpain Proteolytic Systems  |
Takuro Miyazaki/Showa University, Japan |
10:50-11:00 |
Discussion |
KSoLA 2 |
April 20, 11:10-12:40 Rm. 107 |
Understanding Cardiometabolic Nutrition: A Cell to Neighborhood Perspective |
Chairpersons |
¼È«¼®, À̸í¼÷ |
Panel |
°ÇöÀç, ±è»óÇö, ±èÀçÅÃ, ½Å¹ÎÁ¤, ÀÌ»óÇÐ |
11:10-11:30 |
Ectopic Olfactory Receptors Regulate Cellular Lipid Metabolism and Adiposity  |
À̼ºÁØ/°í·Á´ë |
11:30-11:50 |
Nutritional Systems Biology Approach for Understanding Homeostatic Protection of Botanical Phytochemicals Against Vascular Endothelial Dysfunction in Human Clinical Trials |
±Ç¿À¶õ/ÀÌÈ¿©´ë |
11:50-12:10 |
Social Determinant and Cardiometabolic Risks: Diet as a Mediator |
±è¿À¿¬/µ¿¾Æ´ë |
12:10-12:30 |
Impact of Social Network Characteristics on Cardiometabolic Health  |
±èÇöâ/¿¬¼¼ÀÇ´ë |
12:30-12:40 |
Discussion |
KSoLA 4 |
April 20, 14:30-16:00 Rm. 107 |
Always Curious Questions ; Dyslipidemia and Atherosclerosis |
Chairpersons |
Á¤¸íÈ£, ½ÅÇöÈ£ |
Panel |
±è¿ëÀç, ±èÇзÉ, ¼¿ì±Ù, À¯ÅÂÇö, ÀÓ¿µÈ¿ |
14:30-14:45 |
New Promising Lipid-Modifying Drugs  |
ÀÌ¿ëÈ£/¿¬¼¼ÀÇ´ë |
14:45-15:00 |
Lipid-Lowering Therapy in ESRD Patient  |
ÀåÅÂÀÍ/±¹¹Î°Ç°º¸Çè°ø´Ü |
15:00-15:15 |
Management of Insignificant Arterial Stenosis  |
¹Ú±¤¿/Áß¾ÓÀÇ´ë |
15:15-15:30 |
Exercise for Cardiometabolic Health  |
±è¿µÁÖ/¼º½Å¿©´ë |
15:30-15:45 |
Sleep and Cardiovascular Disease |
¾ç±¤ÀÍ/¼øÃµÇâÀÇ´ë |
15:45-16:00 |
Discussion |
BEC 2 |
April 21, 10:40-12:10 Rm.105 |
Meet the Experts of Biomedical Engineering Society for Circulation 2 |
Chairpersons |
À̰èÇÑ, ±è»ó¿í |
Panel |
¼Û½Ã¸ó, À¯À翵, ÀÌ»ó¿í, ÀåÇõÀç |
10:40-10:57 |
Current Unmet Needs for Cerebro-Vascular Diseases |
ÀÌ»óÇü/¼¿ïÀÇ´ë |
10:57-11:14 |
Cerebral Venous Hemodynamics and Cerebrospinal Fluid |
½ÉÀºº¸/°¿ø´ë |
11:14-11:31 |
Hemorheologic Characteristics in Women According as Menstruation Cycle |
À̺´±Ç/¿¬¼¼ÀÇ´ë |
11:31-11:48 |
Diagnoses of Aged RBCs and Malaria with Holographic Microscopy & AI |
ÀÌ»óÁØ/POSTECH |
11:48-12:10 |
Discussion |
* POSTECH : Pohang University of Science and Technology |